vs

Side-by-side financial comparison of Baird Medical Investment Holdings Ltd (BDMD) and OptimumBank Holdings, Inc. (OPHC). Click either name above to swap in a different company.

OptimumBank Holdings, Inc. is the larger business by last-quarter revenue ($13.6M vs $8.0M, roughly 1.7× Baird Medical Investment Holdings Ltd). OptimumBank Holdings, Inc. runs the higher net margin — 35.7% vs -142.7%, a 178.4% gap on every dollar of revenue. OptimumBank Holdings, Inc. produced more free cash flow last quarter ($16.9M vs $-3.2M).

Baird Medical Investment Holdings Ltd is a healthcare-focused investment holding company mainly operating in the Chinese market. It invests in and manages businesses covering in vitro diagnostic devices, medical consumables, and community healthcare services, serving clinical institutions and individual consumers.

OptimumBank Holdings, Inc. is a Florida-based bank holding company operating the local community bank OptimumBank. It offers retail and commercial banking products including deposit accounts, loans, mortgage services and wealth management, serving individual consumers and small-to-medium enterprises in southern Florida.

BDMD vs OPHC — Head-to-Head

Bigger by revenue
OPHC
OPHC
1.7× larger
OPHC
$13.6M
$8.0M
BDMD
Higher net margin
OPHC
OPHC
178.4% more per $
OPHC
35.7%
-142.7%
BDMD
More free cash flow
OPHC
OPHC
$20.2M more FCF
OPHC
$16.9M
$-3.2M
BDMD

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
BDMD
BDMD
OPHC
OPHC
Revenue
$8.0M
$13.6M
Net Profit
$-11.4M
$4.9M
Gross Margin
82.1%
Operating Margin
-131.3%
47.5%
Net Margin
-142.7%
35.7%
Revenue YoY
32.0%
Net Profit YoY
22.9%
EPS (diluted)
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BDMD
BDMD
OPHC
OPHC
Q4 25
$13.6M
Q3 25
$13.0M
Q2 25
$8.0M
$12.1M
Q1 25
$10.7M
Q4 24
$10.3M
Q3 24
$10.1M
Q2 24
$9.9M
Q1 24
$9.0M
Net Profit
BDMD
BDMD
OPHC
OPHC
Q4 25
$4.9M
Q3 25
$4.3M
Q2 25
$-11.4M
$3.6M
Q1 25
$3.9M
Q4 24
$3.9M
Q3 24
$3.3M
Q2 24
$3.5M
Q1 24
$2.4M
Gross Margin
BDMD
BDMD
OPHC
OPHC
Q4 25
Q3 25
Q2 25
82.1%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
BDMD
BDMD
OPHC
OPHC
Q4 25
47.5%
Q3 25
43.5%
Q2 25
-131.3%
40.2%
Q1 25
48.8%
Q4 24
51.5%
Q3 24
44.0%
Q2 24
46.9%
Q1 24
35.9%
Net Margin
BDMD
BDMD
OPHC
OPHC
Q4 25
35.7%
Q3 25
33.2%
Q2 25
-142.7%
29.8%
Q1 25
36.3%
Q4 24
38.3%
Q3 24
32.8%
Q2 24
35.2%
Q1 24
26.4%
EPS (diluted)
BDMD
BDMD
OPHC
OPHC
Q4 25
$-0.08
Q3 25
$0.18
Q2 25
$0.29
Q1 25
$0.32
Q4 24
$-0.17
Q3 24
$0.15
Q2 24
$0.34
Q1 24
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BDMD
BDMD
OPHC
OPHC
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$35.6M
$121.9M
Total Assets
$77.0M
$1.1B
Debt / EquityLower = less leverage
0.24×

8-quarter trend — quarters aligned by calendar period.

Total Debt
BDMD
BDMD
OPHC
OPHC
Q4 25
Q3 25
Q2 25
$8.4M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BDMD
BDMD
OPHC
OPHC
Q4 25
$121.9M
Q3 25
$116.9M
Q2 25
$35.6M
$111.3M
Q1 25
$108.0M
Q4 24
$103.2M
Q3 24
$92.7M
Q2 24
$87.0M
Q1 24
$83.0M
Total Assets
BDMD
BDMD
OPHC
OPHC
Q4 25
$1.1B
Q3 25
$1.1B
Q2 25
$77.0M
$999.1M
Q1 25
$977.5M
Q4 24
$932.9M
Q3 24
$945.2M
Q2 24
$899.8M
Q1 24
$940.6M
Debt / Equity
BDMD
BDMD
OPHC
OPHC
Q4 25
Q3 25
Q2 25
0.24×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BDMD
BDMD
OPHC
OPHC
Operating Cash FlowLast quarter
$-3.2M
$17.8M
Free Cash FlowOCF − Capex
$-3.2M
$16.9M
FCF MarginFCF / Revenue
-40.7%
124.6%
Capex IntensityCapex / Revenue
0.6%
6.6%
Cash ConversionOCF / Net Profit
3.68×
TTM Free Cash FlowTrailing 4 quarters
$27.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BDMD
BDMD
OPHC
OPHC
Q4 25
$17.8M
Q3 25
$1.9M
Q2 25
$-3.2M
$6.2M
Q1 25
$3.1M
Q4 24
$15.6M
Q3 24
$4.0M
Q2 24
$3.1M
Q1 24
$2.5M
Free Cash Flow
BDMD
BDMD
OPHC
OPHC
Q4 25
$16.9M
Q3 25
$1.9M
Q2 25
$-3.2M
$5.9M
Q1 25
$2.9M
Q4 24
$14.6M
Q3 24
$3.9M
Q2 24
$2.7M
Q1 24
$2.3M
FCF Margin
BDMD
BDMD
OPHC
OPHC
Q4 25
124.6%
Q3 25
14.7%
Q2 25
-40.7%
48.5%
Q1 25
26.8%
Q4 24
141.9%
Q3 24
38.3%
Q2 24
27.5%
Q1 24
25.4%
Capex Intensity
BDMD
BDMD
OPHC
OPHC
Q4 25
6.6%
Q3 25
0.0%
Q2 25
0.6%
2.5%
Q1 25
2.7%
Q4 24
9.6%
Q3 24
1.5%
Q2 24
3.6%
Q1 24
2.9%
Cash Conversion
BDMD
BDMD
OPHC
OPHC
Q4 25
3.68×
Q3 25
0.44×
Q2 25
1.71×
Q1 25
0.81×
Q4 24
3.95×
Q3 24
1.21×
Q2 24
0.89×
Q1 24
1.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons